IRIS Accounts Production v23.4.0.336 12305964 Board of Directors 1.1.23 31.12.23 31.12.23 27.3.24 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123059642022-12-31123059642023-12-31123059642023-01-012023-12-31123059642021-12-31123059642022-01-012022-12-31123059642022-12-3112305964ns15:EnglandWales2023-01-012023-12-3112305964ns14:PoundSterling2023-01-012023-12-3112305964ns10:Director12023-01-012023-12-3112305964ns10:CompanyLimitedByGuarantee2023-01-012023-12-3112305964ns10:SmallEntities2023-01-012023-12-3112305964ns10:Audited2023-01-012023-12-3112305964ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3112305964ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3112305964ns10:FullAccounts2023-01-012023-12-3112305964ns10:Director22023-01-012023-12-3112305964ns10:Director32023-01-012023-12-3112305964ns10:Director42023-01-012023-12-3112305964ns10:Director52023-01-012023-12-3112305964ns10:Director62023-01-012023-12-3112305964ns10:Director72023-01-012023-12-3112305964ns10:CompanySecretary12023-01-012023-12-3112305964ns10:RegisteredOffice2023-01-012023-12-3112305964ns5:CurrentFinancialInstruments2023-12-3112305964ns5:CurrentFinancialInstruments2022-12-3112305964ns5:RetainedEarningsAccumulatedLosses2023-12-3112305964ns5:RetainedEarningsAccumulatedLosses2022-12-311230596412023-01-012023-12-3112305964ns5:PlantMachinery2023-01-012023-12-3112305964ns5:PlantMachinery2022-12-3112305964ns5:PlantMachinery2023-12-3112305964ns5:PlantMachinery2022-12-3112305964ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3112305964ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3112305964ns5:WithinOneYear2023-12-3112305964ns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 12305964 (England and Wales)










MOONDANCE CANCER INITIATIVE

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023






MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MOONDANCE CANCER INITIATIVE

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mrs D M De I'Isle-Engelhardt
H A Engelhardt
T D L Crosby
Dr K Hawthorne
Mrs E Neil
Dr D Gillen
G P Graham



SECRETARY: Mrs R S Watkins



REGISTERED OFFICE: 12 Cathedral Road
Cardiff
CF11 9LJ



REGISTERED NUMBER: 12305964 (England and Wales)



SENIOR STATUTORY AUDITOR: Michael Jones



AUDITORS: Bevan Buckland LLP
Chartered Accountants
And Statutory Auditors
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,799 2,345

CURRENT ASSETS
Debtors 5 3,114 1,857
Cash at bank 565,156 398,638
568,270 400,495
CREDITORS
Amounts falling due within one year 6 570,963 405,427
NET CURRENT LIABILITIES (2,693 ) (4,932 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(894

)

(2,587

)

RESERVES
Income and expenditure account (894 ) (2,587 )
(894 ) (2,587 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 March 2024 and were signed on its behalf by:





G P Graham - Director


MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

Moondance Cancer Initiative is a private company, limited by guarantee , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements re rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.


Going Concern
The financial statements currently show the company has negative liabilities of £894 (2022 £2,587). The company has committed funding from Moondance Foundation. The directors deem the company to have sufficient cash reserves to meet its obligations and liabilities as they fall due.

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on cost

Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.


MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to surplus or deficit on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2022 - 11 ) .

MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2023 5,115
Additions 1,322
At 31 December 2023 6,437
DEPRECIATION
At 1 January 2023 2,770
Charge for year 1,868
At 31 December 2023 4,638
NET BOOK VALUE
At 31 December 2023 1,799
At 31 December 2022 2,345

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other debtors 3,114 1,857

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 570,963 405,427

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2023 2022
£    £   
Within one year - 4,631

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Michael Jones (Senior Statutory Auditor)
for and on behalf of Bevan Buckland LLP

MOONDANCE CANCER INITIATIVE (REGISTERED NUMBER: 12305964)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

9. RELATED PARTY DISCLOSURES

Included in income in the year, are donations received from Moondance Foundation, a charitable company who's Trustees, Diane De I'Isle-Engelhardt and Henry Engelhardt and director's of this company.

2023 2022
£    £   
Moondance Foundation 1,982,427 1,552,292


10. LIMITED BY GUARANTEE

The company is limited by guarantee, not having a share capital and consequently the liability of members is limited, subject to an understanding by each member to contribute to the net assets of liabilities of the company on winding up such amounts as may be required not exceeding £1.